Outcomes
What were the main findings from the studies?
- MICARDIS® 80 mg once daily consistently showed superior reduction in blood pressure in the last 6 hours of the dosing interval compared with ramipril 10 mg in both studies.2,3
- MICARDIS® significantly reduced 24-hour mean, morning, daytime and night-time blood pressure compared with ramipril 10 mg.2,3
- MICARDIS® was well tolerated, with a lower incidence of cough than seen with ramipril.2,3
MICARDIS® was more effective than ramipril at reducing blood pressure in the last 6 hours of the dosing interval
MICARDIS® was more effective than ramipril at reducing blood pressure in the last 6 hours of the dosing interval
MICARDIS® was consistently more effective than ramipril at reducing DBP during the morning, daytime, and at night
MICARDIS® was consistently more effective than ramipril at reducing DBP during the morning, daytime, and at night
Both treatments were well tolerated - most adverse events were of mild or moderate intensity. Slightly more patients discontinued ramipril due to adverse events. Incidence of cough was markedly greater with ramipril than with MICARDIS®
Calendar
Tools and Downloads
- Clinical Abstract Library
- Expert Interview Library
- ONTARGET® Results Webcast
- Free ONTARGET® Online Publication Download
- Cardiovascular Risk Guidelines
- Renin Angiotensin System in Cardiovascular Medicine Journal
My Alerts
You will shortly be able to create your own personal alerts service bringing the latest MICARDIS® news and updates direct to your inbox. Watch this space for more information.
/Graph40.jpg)
/Graph41.jpg)
/Graph42.jpg)
/Graph43.jpg)
/Graph44.jpg)